Similar articles

• [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].

  Richaud M, Lechat P, Komajda M, Landault C, Fournier P, Fraysse JB, Grosgogeat Y. Richaud M, et al. Arch Mal Coeur Vaiss. 1990 Feb;83(2):247-52. Arch Mal Coeur Vaiss. 1990. PMID: 1968739 Review. French.
• Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.

  Virk SJ, Davies MK. Virk SJ, et al. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):15S-22S. Br J Clin Pharmacol. 1989. PMID: 2572250 Free PMC article.
• [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].

  Rousseau MF, Cheron P, Nannan M, Vincent MF, Lavenne F, Pouleur H. Rousseau MF, et al. Ann Med Interne (Paris). 1985;136(3):247-50. Ann Med Interne (Paris). 1985. PMID: 2862823 French.
• Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.

  Barnett DB, Breckenridge A. Barnett DB, et al. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):1S-91S. Br J Clin Pharmacol. 1989. PMID: 2572249 Free PMC article. No abstract available.
• Long-term studies with xamoterol in heart failure.

  Waller DG. Waller DG. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):53S-58S. doi: 10.1111/j.1365-2125.1989.tb03573.x. Br J Clin Pharmacol. 1989. PMID: 2572255 Free PMC article. Review.